We are live on ! Find out more
IRC

Investors Research Corp Portfolio holdings

AUM $559M
1-Year Est. Return 21.55%
This Fund
S&P 500
This Quarter Est. Return
+10.98%
1 Year Est. Return
+21.55%
3 Year Est. Return
+57.22%
5 Year Est. Return
+62.75%
10 Year Est. Return
–
AUM
$370M
AUM Growth
+$43.1M
Cap. Flow
+$10.3M
Cap. Flow %
2.78%
Top 10 Hldgs %
17.65%
Holding
1,167
New
15
Increased
142
Reduced
184
Closed
22

Top Buys

Rank Stock Value
1
IP icon
International Paper
IP
+$1.01M
2
WBA
Walgreens Boots Alliance
WBA
+$637K
3
FTCS icon
First Trust Capital Strength ETF
FTCS
+$535K
4
SPYG icon
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
+$502K
5
IWY icon
iShares Russell Top 200 Growth ETF
IWY
+$487K

Top Sells

Rank Stock Value
1
ADEA icon
Adeia
ADEA
+$1.45M
2
HNGR
Hanger Inc.
HNGR
+$521K
3
CF icon
CF Industries
CF
+$130K
4
SPTN
SpartanNash
SPTN
+$58.6K
5
KSS icon
Kohl's
KSS
+$44.6K

Sector Composition

Rank Sector Weight
1 Financials 9.96%
2 Consumer Discretionary 8.58%
3 Technology 5.88%
4 Industrials 5.72%
5 Materials 4.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BDTX icon
1126
Black Diamond Therapeutics
BDTX
$120M
$54 ﹤0.01%
30
– –
LYRA
1127
DELISTED
LYRA THERAPEUTICS INC
LYRA
– –
0
– –
HARP
1128
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$44 ﹤0.01%
6
– –
SRNE
1129
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$44 ﹤0.01%
50
– –
BLCN
1130
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
$41 ﹤0.01%
2
– –
RBOT
1131
DELISTED
Vicarious Surgical
RBOT
$30 ﹤0.01%
1
– –
AMPX.WS icon
1132
Amprius Technologies Warrants
AMPX.WS
$569M
$26 ﹤0.01%
90
– –
BKKT icon
1133
Bakkt Inc
BKKT
$329M
$24 ﹤0.01%
1
– –
YARW
1134
Yarrow Bioscience, Inc. Common Stock
YARW
$115M
– –
0
– –
TCRR
1135
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$15 ﹤0.01%
15
– –
BODI icon
1136
The Beachbody Company
BODI
$45.8M
– –
0
– –
AFRM icon
1137
Affirm
AFRM
$25.7B
$10 ﹤0.01%
1
– –
CDAK
1138
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$9 ﹤0.01%
22
– –
EVGO icon
1139
EVgo
EVGO
$503M
$4 ﹤0.01%
1
– –
ASBPW
1140
Aspire Biopharma Warrant
ASBPW
$483K
$1 ﹤0.01%
10
– –
FATH.WS
1141
DELISTED
Fathom Digital Manufacturing Corporation Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50 per share
FATH.WS
$1 ﹤0.01%
12
– –
CPUH.WS
1142
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$1 ﹤0.01%
12
– –
AES icon
1143
AES
AES
$10.5B
– –
-300
Closed -$7K
DOCU
1144
DocuSign
DOCU
$11.3B
– –
-3
Closed –
GOSS icon
1145
Gossamer Bio
GOSS
$88.9M
– –
-69
Closed -$1K
GXO icon
1146
GXO Logistics
GXO
$5.37B
– –
-4
Closed –
HSY icon
1147
Hershey
HSY
$36.6B
– –
-33
Closed -$7K
LDTC
1148
DELISTED
LeddarTech
LDTC
– –
-132
Closed -$1K
LDTCW
1149
DELISTED
LeddarTech Holdings Inc. Warrants
LDTCW
$0 ﹤0.01%
22
– –
CPUH
1150
DELISTED
Compute Health Acquisition Corp.
CPUH
– –
-48
Closed –
43 44 45
46
47

Similar funds

DIM
Delta Investment Management San Francisco, California $559M AUM 19.86% 1-Year Est. Return
CFP
Curran Financial Partners Daniel Island, South Carolina $559M AUM 13.69% 1-Year Est. Return
TCM
Thames Capital Management Roseland, New Jersey $558M AUM 236.21% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.81% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $560M AUM 62.9% 1-Year Est. Return
CAM
Cander Asset Management New York $557M AUM
MCM
Maytus Capital Management New York $562M AUM 71.97% 1-Year Est. Return
FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Investors Research Corp's Q4 2022 Portfolio in Review

As of Q4 2022, Investors Research Corp held 1,167 positions worth $370M, up 13% from $327M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 3.2%. Investors Research Corp opened 15 new positions and exited 22, leaving the 1,167-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 10% of assets, down from 10% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Investors Research Corp's largest Q4 2022 buy was Xperi: 8,586 shares worth $73.9K.
  • Investors Research Corp added most to International Paper in Q4 2022, an estimated $1.01M increase.
  • Investors Research Corp's biggest Q4 2022 reduction was Adeia, cutting an estimated $1.45M.
  • Investors Research Corp fully exited Hanger Inc. in Q4 2022, selling an estimated $521K.
  • Investors Research Corp's ten largest holdings make up 18% of its $370M portfolio in Q4 2022.
  • Investors Research Corp opened 15 new positions and closed 22 in Q4 2022.
  • Investors Research Corp's portfolio value rose 13% quarter-over-quarter to $370M.

Based on Investors Research Corp's 13F filing for Q4 2022, filed 6 Feb 2023.